drugset / Trial / NCT02842073
An Open Label Trial of Bupropion and Naltrexone for Binge Drinking
Phase 2
Completed
12 enrolled
University of North Carolina, Chapel Hill
North Carolina Translational and Clinical Sciences Institute · collab
NaSingle-groupOpen-labelTreatment
Summary
This is an open-label Phase IIa pilot study of the tolerability and effects on binge drinking of bupropion and naltrexone for binge drinkers.
Timeline
- Start
- 2016-11-01
- Primary completion
- 2017-12-13
- Completion
- 2017-12-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupropion | Small molecule | 300 mg | — |
| Subject | Naltrexone | Small molecule | 50 mg | — |